Doseform

What Doseform does

Doseform Inc. was a privately held, Austin-based pharmacy patient engagement SaaS company (founded 2021, 1-10 employees) that built an AI-driven, HIPAA-compliant platform enabling pharmacies to communicate with patients via two-way SMS, email, and digital intake forms without requiring an app download or account registration. The platform's modular product suite covered the full prescription journey — HIPAA eConsent collection, order notification, mobile payment, delivery/pickup selection, shipping updates, refill reminders, adherence prompts, clinical surveys, patient satisfaction surveys, and insurance information updates — unified by an omnichannel personalization engine targeting the right message to the right patient across channels. The technical architecture was anchored in healthcare-specific compliance: SOC 2 Type II certification (audited by Accorp Partners with an unqualified opinion), full HIPAA/HITECH compliance under the Omnibus Rule with PHI encryption at rest and in transit, and PCI compliance for payment processing. Product capabilities centered on conversational text automation for routine patient questions, prescription order confirmation and mobile payment, and digital questionnaires for refills, satisfaction, and accreditation/insurance audit compliance.

The company operated a volume-tiered SaaS subscription model priced on monthly prescription volume (tiers from 0-5,000 to 30,000+ prescriptions/month), sold through an enterprise demo-based sales motion targeting national and regional pharmacy chains, health system pharmacies, and independent community pharmacies, with a white-label OEM channel enabling partners (including ManifestRx, Cloud9 Healthcare, and a "White Label" partner) to embed the technology under their own brands. Marketing was content-led — an active blog authored under the byline "Tochi Yaba," a presence at ViVE 2024, and demo-request capture — targeting the operational pain points of high inbound call volume, reactive issue resolution, insurance compliance calls, and prescription abandonment (cited at 9% new-prescription abandonment per IQVIA and 20-30% daily reversal rates). Doseform raised only $100,000 in disclosed seed funding (March 2023, Forum Ventures and Right Side Capital Management) and was acquired by ReviveHealth, Inc. on February 12, 2026, transferring the platform into ReviveHealth's national pharmacy footprint as part of an integrated pharmacy technology suite.

Name

Doseform

Legal name

Doseform Inc.

Website

https://doseform.com

Company type

Private

Founded year

2021

Operating status

Acquired

Headcount range

1–10 employees

Short description

Doseform is an Austin-based, HIPAA-compliant SaaS platform that automates pharmacy patient engagement via two-way SMS, mobile payments, refill reminders, and digital surveys, serving pharmacy chains, health systems, and white-label partners; acquired by ReviveHealth in February 2026.

Ownership category

akta.pro rank

Product category

Pharmacy Patient Engagement Software

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)

akta.pro secondary industries

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG), PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL)

Keywords

• Pharmacy patient engagement
• Prescription workflow automation
• Medication adherence software
• Healthcare messaging platform
• Compliance-ready communications

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Platform Subscription: Pharmacy-focused patient engagement platform sold as a subscription to pharmacy chains and healthcare organizations. The platform automates prescription workflows, patient communications, and payment processing. Pricing is customized based on prescription volume and organizational needs.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Doseform is a HIPAA-compliant, AI-driven pharmacy patient engagement and automation platform that enables two-way conversational texting between pharmacies and patients, automates prescription order confirmations and mobile payments, and delivers digital surveys for refills, satisfaction, and insurance/audit compliance. The platform requires no app download or patient registration and can be white-labeled for pharmacy partners. It is sold as a SaaS subscription to pharmacy chains, health systems, and independent pharmacies.

Product overview

Doseform is a pharmacy-focused patient engagement and automation platform built as a unified product with multiple integrated modules. The core Doseform Platform provides proactive, conversational two-way communication capabilities between pharmacies and patients. The platform includes patient-facing modules for order notifications, online payment processing, delivery/pickup options, and shipping updates, as well as clinical engagement modules for HIPAA eConsent collection, refill reminders, adherence prompts, clinical surveys, patient satisfaction surveys, and insurance updates. The system leverages an omnichannel personalization engine to deliver targeted messaging via SMS, email, and digital intake forms without requiring patients to download an app or create an account. The platform is SOC 2 Type II certified and HIPAA/HITECH compliant.

Differentiator

Problem solved

Functional benefit

Products and services

• Doseform Platform A pharmacy-focused patient engagement and automation platform that enables proactive, conversational two-way communication between pharmacies and patients via SMS, email, and digital intake forms. The unified platform bundles HIPAA eConsent collection, order and shipping notifications, online payment, delivery/pickup options, refill reminders, adherence prompts, clinical and patient satisfaction surveys, and insurance updates; it is white-label capable and requires no patient app download or account registration.

Quantifiable outcome

• 94% patient satisfaction ratings
• +4 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

One partnership is on record.

• ReviveHealthcoreStrategic or Co-development Partner · 12 February 2026ReviveHealth, Inc. acquired Doseform in February 2026 to strengthen its integrated pharmacy technology across its national pharmacy footprint. The acquisition gives ReviveHealth ownership of Doseform's core AI-driven patient engagement platform, providing greater control, reduced long-term cost risk, and scalable growth capacity for its pharmacy operations. Doseform's two-way messaging platform streamlines prescription workflows, payments, and patient communications while reducing inbound call volume and operational friction.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• mPulse Mobile: mPulse Mobile delivers two-way SMS and omnichannel patient engagement for healthcare, including pharmacy and medication-adherence programs — overlapping Doseform's core AI-driven conversational texting and refill reminder capabilities.
• Digital Pharmacist: Digital Pharmacist provides patient engagement, refill reminders, and communication tools specifically built for retail and independent pharmacies — directly competing with Doseform in the pharmacy patient communication category with similar HIPAA-compliant messaging and adherence functionality.
• Relatient: Relatient provides patient engagement (texting, reminders, surveys, payments) for medical practices and pharmacy-adjacent workflows — directly comparable to Doseform's omnichannel pharmacy engagement modules.
• Weave: Weave is a patient communication and engagement platform widely used by healthcare practices including pharmacies, offering two-way texting, online payments, and review/survey tools that overlap heavily with Doseform's feature set.
• Solutionreach: Solutionreach delivers patient communication, recall/reminder, and survey tools across healthcare — offering refill and adherence-adjacent functionality that competes with Doseform's prescription reminder and clinical survey modules.
• Podium: Podium offers a messaging and payments platform adopted by healthcare and pharmacy businesses for patient texting, online payment, and review requests — competing with Doseform's mobile-payment and two-way messaging workflows.

Broad incumbents

• Twilio: Twilio provides the underlying programmable messaging, voice, and payments APIs that healthcare vendors — including pharmacy engagement platforms — build on. Its Segment and Flex products could enable larger pharmacy chains to replicate Doseform's functionality in-house.
• Omnicell: Omnicell is a large pharmacy automation and medication management vendor offering patient engagement and adherence solutions as part of its broader pharmacy technology portfolio — competing with Doseform through bundled enterprise offerings to large health systems and pharmacy chains.

Emerging players

• Luma Health: Luma Health is a patient engagement platform focused on appointment reminders, intake forms, and two-way messaging — overlapping Doseform's digital questionnaire and patient communication capabilities but with broader provider focus beyond pharmacies.
• Klara: Klara is a patient messaging and workflow platform for healthcare practices with HIPAA-compliant texting and intake — adjacent to Doseform's pharmacy-focused two-way messaging and digital questionnaire features.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/Doseform
• Facebookfacebook.com/doseform
• LinkedInlinkedin.com/company/doseform

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doseform